Abstract
Venous thromboembolism (VTE) occurs in 0.95–36 % of children with acute lymphoblastic leukemia almost exclusively during chemotherapy. It is most commonly associated with concurrent l-asparaginase and steroid therapy, central venous line use, and inherited thrombophilia. Clinical manifestations regarding the location of VTE include central nervous system thrombosis (sinus venous thrombosis, cerebral infarct/stroke), upper-/lower-limb deep venous thrombosis, pulmonary embolism, and right atrial/intracardiac and superficial venous thrombosis and can be both symptomatic and asymptomatic. The majority of thrombotic events are central catheter related. Doppler ultrasound, venography, computed tomography, magnetic resonance imaging, magnetic resonance angiography, ventilation/perfusion scans, and echocardiogram are the methods used in VTE detection. The standard management is l-asparaginase discontinuation and low-molecular-weight heparin (LMWH) at 1 mg/kg/dose twice a day (enoxaparin initial therapeutic dose) followed by achieving a serum anti-Xa level of 0.5–1.0 IU/ml for 1–3 months and maintaining this level at 0.1–0.3 IU/ml until the reversible risk factors are resolved. The restarted l-asparaginase treatment associated with the highest risk of VTE recurrence should be covered with LMWH prophylaxis. The cerebral sinus venous thrombosis is associated with the most unfavorable prognosis and requires aggressive therapy. Thrombosis prevention in pediatric acute lymphoblastic leukemia is warranted, but the standards of methods and schedules are unknown.
Similar content being viewed by others
References
Santoro N, Colombini A, Silvestri D, et al. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience. J Pediatr Hematol Oncol. 2013;35(5):348–55.
Nowak-Göttl U, Kenet G, Mitchell LG, et al. Thrombosis in childhood acute lymphoblastic leukaemia: epidemiology, aetiology, diagnosis, prevention and treatment. Best Pract Res Clin Haematol. 2009;22(1):103–14.
Caruso V, Iacoviello L, Di Castelnuovo A, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108(7):2216–22.
Giordano P, Molinari AC, Del Vecchio GC, et al. Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia. Am J Hematol. 2010;85(5):325–30.
Mitchell L, Lambers M, Flege S, et al. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010;115(24):4999–5004.
Nowak-Góttl U, Kurnik K. Thrombophilia in the young. Hamostaseologie. 2008;28(1–2):16–20.
Zia AN, Chitlur M. Management of thrombotic complications in acute lymphoblastic leukemia. Indian J Pediatr. 2013;80(10):853–62.
Grace RF, Dahlberg SE, Neuberg D, et al. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols Br J Haematol. 2011;152(4):452–9.
Monagle P, Chan AK, Goldenberg NA, American College of Chest Physicians, et al. Antithrombotic therapy in neonates and children: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl.):e737S–801S.
Wang TY, Yen HJ, Hung GY, et al. A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia: superior sagittal sinus thrombosis. J Chin Med Assoc. 2011;74(4):183–7.
Hofmann S, Knoefler R, Lorenz N, et al. Clinical experiences with low-molecular weight heparins in pediatric patients. Thromb Res. 2001;103:345–53.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Skalska-Sadowska, J., Derwich, K. Venous thromboembolism in children with acute lymphoblastic leukemia. memo 7, 148–151 (2014). https://doi.org/10.1007/s12254-014-0163-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12254-014-0163-7